On Monday, Vicor cleared a noteworthy performance benchmark, with its Relative Strength (RS) Rating entering into the 90-plus percentile with an upgrade to 91, a rise from 88 the day before.
IBD's unique RS Rating identifies technical performance by using a 1 (worst) to 99 (best) score that shows how a stock's price performance over the last 52 weeks matches up against other publicly traded companies.
History shows that the stocks that go on to make the biggest gains often have an 80 or better RS Rating at the beginning of a new climb.
Looking For The Best Stocks To Buy And Watch? Start Here
Vicor has climbed more than 5% past a 48.20 entry in a first-stage consolidation, meaning it's now out of a proper buy zone. Look for the stock to create a new buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week line.
While EPS growth fell in the company's most recently reported quarter from 0% to -30%, the top line grew -14%, up from -20% in the previous report.
The company earns the No. 12 rank among its peers in the Electronics-Parts industry group. Amphenol Cl A, Coherent and NVECorp are among the top 5 highly rated stocks within the group.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
